NASDAQ:INMD

18.21
0.12 (0.65%) 1d
0
Investor Insights

This summary was created by AI, based on 5 opinions in the last 12 months.

InMode (INMD-Q) is a medical devices company focusing on aesthetics, with strong cash generation and high free cash flows. Despite a decline in revenue and potential tax-loss selling due to being based in Israel, the company plans to launch two new platforms which could help revenue growth. The company has clean balance sheet and potential for upside. While there are concerns about consumer demand, higher interest rates, and the lawsuit, experts recommend holding the stock and exercising patience for potential growth.

Consensus
Hold
Valuation
Undervalued
HOLD
InMode
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

In Q4, INMD beat EPS estimates of $0.64 coming in at $0.71. Revenue missed estimates of $127.29M coming in at $126.8M and declined 5% on a year-over-year basis. Guidance called for fiscal 2024 non-GAAP EPS of $2.53 to $2.57 and revenue between $495M to $505M. Analysts expected lower EPS guidance while revenue was forecasted to fall within the range guided. INMD certainly has plenty of cash and continues to generate high free cash flows while guidance appeared better than expected. One area for optimisim is that the company plans on launching two new platforms this year which could help revenue growth. Outside of the drop in revenue, the balance sheet, margins, and cash generation remain strong. We would hold here and see how things progress in coming quarters. It is becoming a bit of a value trap, but it is not without some potential. 
Unlock Premium - Try 5i Free

0
HOLD
InMode
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

The revenue guidance cut is not great, of course. But it does seem to be related to consumer demand and higher interest rates, as opposed to something the company 'did' or a missed opportunity. In the lawsuit INMD is the plantiff, and we would not see it as too concerning. But INMD also has the problem of being based in Israel, and investors will likely avoid it for a while. Plus, we could see some tax-loss selling. It is 8X earnings and has $574M cash, so it is going to get through this slump. We think it will bounce, but can't time it. To hold we think investors will need to have at least a year of patience. We could see it as a tax loss sale/rebuy next year, but would not be too interested in selling in the short term after this sharp decline. 
Unlock Premium - Try 5i Free

0
BUY
InMode

A medical devices company focusing on aesthetics. People are spending on looking good, if there won't be a recession. Trades at 11x PE. Lots of upside.

0
BUY
InMode

Medical devices business keeps recovering and the stocks are getting their due. Reported a 43% increase in consumables and service revenue for Q1-2023 in a strong quarter. Puzzled that shares slumped after the company didn't revise its full-year forecast. Still, shares are up 47% in the past year. A buy at 13x PE.

0
BUY
InMode

A medical device company. Clean balance sheet and a cheap stock. Last week they pre-announced a stronger than expected quarter. Shares jumped 5% that day. Could have more upside.

0
DON'T BUY
InMode

Seemingly checks a lot of boxes. But about 70-80% of earnings are from one-time sales. Not a lot of repeat business. Only 20-30% of revenues are recurring or add-ons. Potentially disruptive space. The pursuit of M&A can often destroy shareholder value.

0
Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

InMode(INMD-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for InMode is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

InMode(INMD-Q) Frequently Asked Questions

What is InMode stock symbol?

InMode is a American stock, trading under the symbol INMD-Q on the NASDAQ (INMD). It is usually referred to as NASDAQ:INMD or INMD-Q

Is InMode a buy or a sell?

In the last year, 3 stock analysts published opinions about INMD-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for InMode.

Is InMode a good investment or a top pick?

InMode was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for InMode.

Why is InMode stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is InMode worth watching?

3 stock analysts on Stockchase covered InMode In the last year. It is a trending stock that is worth watching.

What is InMode stock price?

On 2024-06-13, InMode (INMD-Q) stock closed at a price of $18.21.